Postural Kinesio Taping in Stroke Rehabilitation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBursa City Hospital

About this trial

Stroke often leads to postural asymmetry and impaired trunk control, which negatively affect mobility, balance, coordination, and activities of daily living. These impairments increase the risk of falls and reduce functional independence during the rehabilitation process.

The purpose of this randomized controlled trial is to investigate the effects of posture-oriented kinesio taping, applied in addition to standard neurological rehabilitation, on functional outcomes in patients with stroke. Participants will be randomly assigned to either an intervention group receiving kinesio taping plus standard rehabilitation or a control group receiving standard rehabilitation alone.

Functional outcomes including trunk control, postural stability, balance, mobility, and activities of daily living will be assessed using validated clinical scales at baseline and after the intervention period. The findings of this study are expected to provide evidence regarding the clinical effectiveness of posture-oriented kinesio taping as a non-invasive and easily applicable adjunct treatment in stroke rehabilitation.

Eligibility criteria

Qualifiers

Adults aged 18 years or older

Diagnosis of ischemic or hemorrhagic stroke confirmed clinically and/or radiologically

In the subacute or chronic phase of stroke (≥1 month post-stroke) and clinically stable

Presence of postural control and/or trunk control impairment

Disqualifiers

Acute stroke phase or clinical instability

Severe cognitive impairment, aphasia, or insufficient cooperation that would interfere with reliable outcome assessments

Known allergy or hypersensitivity to kinesio tape

Active dermatological conditions at taping sites (e.g., open wounds, dermatitis, infection)

Trial design

Treatments tested in this trial

  • Posture-Oriented Kinesio Taping
  • Standard Rehabilitation

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators